ITEM 7.01. Regulation FD Disclosure.
On January 13, 2021, members of management for OPKO Health, Inc. (the "Company")
took part in the 39th Annual J.P. Morgan Healthcare Conference and participated
in one on one meetings with investors. A copy of the Company's presentation as
used in the meetings is furnished as Exhibit 99.1 to this Current Report on Form
8-K and incorporated herein by reference. The presentation is also available on
the Company's website at www.opko.com under Investor Relations. The information
contained on the Company's website shall not be deemed part of this report.
The information contained in Item 7.01 to this Current Report on Form 8-K and
Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing by the Company under the Securities Act
of 1933, as amended, or the Exchange Act, unless expressly stated otherwise.
ITEM 8.01. Other Events.
On January 13, 2021, the Company's BioReference Laboratories, Inc. introduced
Scarlet Health™, an in-home, fully integrated digital platform providing access
to on-demand diagnostic services.
ITEM 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 OPKO Health, Inc. Presentation Materials
99.2 Press Release of the Company dated January 13, 2021
104 Cover Page Interactive Data File-the cover page XBRL tags are embedded
within the Inline XBRL document
--------------------------------------------------------------------------------
Exhibit Index
Exhibit No. Description
99.1 OPKO Health, Inc. Presentation Materials
99.2 Press Release of the Company dated January 13, 2021--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
OPKO HEALTH, INC. 
